Sectors
Pancreatic Cancer Trial Ahead of Schedule, Gastric Cancer Fast Track Win
A drug called givastomig produced a 77% response rate in gastric cancer. The stock trades 71% below its 52-week high. Sometimes the data and the price tell two different stories. AIM ImmunoTech Doses Final Patient in Phase 2 Pancreatic Cancer Trial Ahead of Schedule AIM ImmunoTech (NYSE American: AIM) had a busy stretch in the…
Banyan Gold 62.66 g/t Yukon Find and Formation Metals N2 Extension
Gold averaged $3,300 an ounce this month. At a 0.30 g/t cutoff, that turns marginal rock into ore. Banyan Gold just drilled 62.66 grams per tonne. That is not marginal rock. Banyan Gold Intersects 62.66 g/t Gold in a New High-Grade Zone at the Powerline Deposit, Yukon Banyan Gold Corp. (TSXV: BYN / OTCQB: BYAGF)…
Kevin Warsh’s First Fed Meeting Gave Crypto Nothing and the Market Noticed
There is a kind of financial product whose entire selling point is that it does not do anything interesting. A preferred stock priced at $100 par, paying a steady dividend, designed to sit there and throw off income while the people who bought it go about their lives. On June 18, one of these instruments…
OpenAI Burned $3.7 Billion in Q1 and Filed for a $1 Trillion IPO in the Same Week
OpenAI made $5.7 billion in the first quarter of 2026. It spent $3.7 billion of that. Both numbers tripled year on year. The company then filed confidentially for an IPO that a source told Reuters could value it at up to $1 trillion. There is a version of this story where the revenue growth curve…
Hut 8 Closes $4.25B AI Bond and Coinbase Launches Crypto Agents
Bitcoin mining companies used to fund themselves by selling the coins they dug up. Hut 8 just raised $4.25 billion in bonds. These are not the same business model. Hut 8 Closes $4.25 Billion Texas AI Data Center Bond and Appoints Stanley O’Neal as Chairman On June 10, Hut 8 Corp. (Nasdaq: HUT) closed a…
Auvelity FDA Approval Launches the First Non-Antipsychotic Market for Alzheimer Agitation
Roughly 39 million people live with HIV. Most of them are on treatment. A large proportion of those people are aging, developing comorbidities, accumulating drug resistance, and managing the complexity of multi-tablet regimens that have kept the virus suppressed but come with their own set of problems. Gilead Sciences has a drug in FDA review…
374Water PFAS Capacity Upgrade and PureCycle Packaging Milestone
PFAS has been detected in the blood of 97% of Americans. It does not biodegrade. Most technologies capture it, concentrate it, or move it somewhere else. 374Water’s technology destroys it permanently. On June 9, the company upgraded the facility that does that. 374Water Expands Iron Bridge Facility Targeting $3 Million to $5 Million in Annual…
Siri Gets Rebuilt, SpaceX Goes Public: The Week That Changed AI Markets
Siri has been the butt of the joke for five years. On June 8, Apple spent $1 billion to fix that. Apple WWDC 2026 Reveals Siri AI Powered by Custom 1.2 Trillion Parameter Gemini Model Apple’s Worldwide Developers Conference opened June 8 at Apple Park. The keynote landed with a specific number: 1.2 trillion parameters.…
Triple Flag Acquires $440 Million Ravenswood Gold Stream as Royalty Market Accelerates
There is a mine in Queensland called Ravenswood. It has been producing gold since 1987 and has pulled more than four million ounces out of the ground since then. Last Friday, someone paid $440 million for the right to buy 5.5% of its future output. That someone was Triple Flag Precious Metals. At $4,700 gold,…
Pancreatic Cancer Phase 3 Starts, Ovarian Cancer Phase 1 Wins
51,000 Americans will be diagnosed with pancreatic cancer this year. Roughly 45,000 will die from it. The five-year survival rate has not meaningfully changed since 2000. On June 11, a company called Immuneering dosed its first Phase 3 patient. Immuneering Corporation Doses First Patient in Phase 3 MAPKeeper 301 Pancreatic Cancer Trial Immuneering Corporation (Nasdaq:…
